- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01756742
Effects of Respiratory Physiotherapy on Pleural Effusion
December 20, 2012 updated by: Marie Carmen Valenza, Universidad de Granada
Effectiveness of a Program of Respiratory Physiotherapy on Pleural Effusion: a Randomized Controlled Trial
Pleural effusion and the complexity of diagnosis and treatment make planning and delivering care challenging.
Respiratory physiotherapy is recommended, and should be applied during the first weeks of treatment.The aim of the present study is to demonstrate the effectiveness of a respiratory physiotherapy protocol in patients with Pleural Effusion who attended a University Hospital.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Approximately 1.5 million patients are diagnosed with pleural effusion each year in the United States .
Pleural effusion (PE) is an accumulation of fluid in the pleural space that is classified as transudate or exudate according to its composition and underlying pathophysiology.
The goal in the management of pleural effusion is to provide symptomatic relief by removing fluid from the pleural space and to allow the treatment of the underlying disease.
While some authors (REF) propose respiratory physiotherapy, in the majority of the cases only the medical treatment combined with the pleural fluid removal by thoracentesis are the most common practice.
The objective of this study is verify the effectiveness of respiratory physiotherapy in pleural effusion
Study Type
Interventional
Enrollment (Actual)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Andalucia
-
Granada, Andalucia, Spain, 18012
- Universitary Hospital San Cecilio
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of pleural effusion based on the presence of a consistent radiological finding on simple posteroanterior and lateral chest X-rays, and decubitus lateral in cases of small PE.
Exclusion Criteria:
- Non diagnosis of pleural effusion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Respiratory physiotherapy
54 people according to the inclusion criteria were recruited to have a respiratory physiotherapy treatment added to their medical intervention.
|
The respiratory physiotherapy intervention included:
Other Names:
|
PLACEBO_COMPARATOR: Conservative treatment
49 people were recruited in this group.
These participants received conservative medical treatment intervention
|
Conservative medical treatment intervention for pleural effusion.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of the severity of respiratory disease
Time Frame: baseline, 12 months
|
A spirometry is used to assess severity of individual patients respiratory disease and their response to therapy and is regarded as the gold standard measure of respiratory function.
The following variables were recorded; forced vital capacity, forced expiratory volume achieved in 1 second, and the forced expiratory flow over the middle one half of the forced vital capacity.
|
baseline, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of the hospital stay
Time Frame: baseline, 12 months
|
Length of stay was defined as the number of days between admission and discharge.
|
baseline, 12 months
|
Severity in the pleural effusion repercussion
Time Frame: baseline, 12 months.
|
The chest radiograph has been the initial diagnostic tool for the detection and evaluation of pleural effusion.
The severity was codified from 0(normal) to 10 (very severe) by a radiologist with more than 8 years of experience.
|
baseline, 12 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: M. Carmen Valenza, MD, Universidad de Granada
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (ACTUAL)
January 1, 2011
Study Completion (ACTUAL)
March 1, 2012
Study Registration Dates
First Submitted
December 20, 2012
First Submitted That Met QC Criteria
December 20, 2012
First Posted (ESTIMATE)
December 27, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
December 27, 2012
Last Update Submitted That Met QC Criteria
December 20, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DF0038UG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Oregon Health and Science UniversityThe Gerber FoundationCompletedChylous Pleural Effusion Following Cardiothoracic SurgeryUnited States
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPleural NeoplasmUnited States
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruiting
-
Washington University School of MedicineMerit Medical Systems, Inc.CompletedMalignant Pleural EffusionUnited States
-
Duke UniversityTerminated
Clinical Trials on Respiratory physiotherapy
-
Bursa Yüksek İhtisas Education and Research HospitalRecruitingVentilators, Mechanical | Pulmonary MedicineTurkey
-
Acibadem UniversityCompletedHeart Diseases | Robotic Surgical ProceduresTurkey
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedCOVID-19 Acute Respiratory Distress SyndromeItaly
-
NUMEN FoundationHospital de Emergencias Enfermera Isabel Zendal de MadridNot yet recruitingCOVID-19 Acute Respiratory Distress Syndrome
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Completed
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Unknown
-
Bezmialem Vakif UniversityCompletedBronchiectasis | Cystic FibrosisTurkey
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Universidad de GranadaCompletedChronic Obstructive Pulmonary DiseaseSpain
-
Guadarrama HospitalFisiobronquial ClínicasCompleted